Showing 1 - 6 results of 6 for search 'V. A. Rogov', query time: 0.07s Refine Results
  1. 1
    PHARMACOECONOMIC STUDY OF LENVIMA (LENVATINIB) IN ADVANCED PROGRESSIVE RADIO IODINE REFRACTORY DIFFERENTIATED THYROID CANCER IN THE RUSSIAN FEDERATION

    PHARMACOECONOMIC STUDY OF LENVIMA (LENVATINIB) IN ADVANCED PROGRESSIVE RADIO IODINE REFRACTORY DIFFERENTIATED THYROID CANCER IN THE RUSSIAN FEDERATION by M. Yu. Frolov, V. A. Rogov

    Published 2016
    Connect to this object online.
    Book
    Save to List
    Saved in:
  2. 2
    EVALUATION OF DRUG THERAPY IN PROGRESSING DIFFERENTIATED THYROID CANCER REFRACTORY TO RADIOACTIVE IODINE IN PATIENTS RESIDING IN THE RUSSIAN FEDERATION : PHARMACOECONOMIC ASPECTS

    EVALUATION OF DRUG THERAPY IN PROGRESSING DIFFERENTIATED THYROID CANCER REFRACTORY TO RADIOACTIVE IODINE IN PATIENTS RESIDING IN THE RUSSIAN FEDERATION : PHARMACOECONOMIC ASPECTS by M. Yu. Frolov, V. A. Rogov

    Published 2017
    Connect to this object online.
    Book
    Save to List
    Saved in:
  3. 3
    PHARMACOECONOMIC JUSTIFICATION OF A WIDER USE OF PREVENTIVE HEMOPHILIA THERAPY IN THE RUSSIAN FEDERATION

    PHARMACOECONOMIC JUSTIFICATION OF A WIDER USE OF PREVENTIVE HEMOPHILIA THERAPY IN THE RUSSIAN FEDERATION by M. Yu. Frolov, V. A. Rogov

    Published 2018
    Connect to this object online.
    Book
    Save to List
    Saved in:
  4. 4
    Evaluation of the economic effect of biological therapy in patients with severe COVID-19 and cytokine storm

    Evaluation of the economic effect of biological therapy in patients with severe COVID-19 and cytokine storm by M. Yu. Frolov, A. S. Salasyuk, V. A. Rogov

    Published 2021
    Connect to this object online.
    Book
    Save to List
    Saved in:
  5. 5
    Cost-effectiveness analysis of the use of mepolizumab in omalizumab-resistant patients with severe asthma

    Cost-effectiveness analysis of the use of mepolizumab in omalizumab-resistant patients with severe asthma by A. G. Tolkushin, V. A. Rogov, D. A. Ivanov, N. L. Pogudina

    Published 2019
    Connect to this object online.
    Book
    Save to List
    Saved in:
  6. 6
    Pharmacoeconomic analysis of thrombopoietin receptor agonists in the treatment of chronic idiopathic thrombocytopenic purpura in adults

    Pharmacoeconomic analysis of thrombopoietin receptor agonists in the treatment of chronic idiopathic thrombocytopenic purpura in adults by E. A. Pyadushkina, M. Yu. Frolov, V. A. Shuvaev, V. A. Rogov

    Published 2018
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: